BRUGGERS v. EASTMAN KODAK CO.

2000 NCBC 3
CourtNorth Carolina Business Court
DecidedMarch 17, 2000
Docket97-CVS-11278
StatusPublished
Cited by2 cases

This text of 2000 NCBC 3 (BRUGGERS v. EASTMAN KODAK CO.) is published on Counsel Stack Legal Research, covering North Carolina Business Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
BRUGGERS v. EASTMAN KODAK CO., 2000 NCBC 3 (N.C. Super. Ct. 2000).

Opinion

BRUGGERS v. EASTMAN KODAK CO., et al., 2000 NCBC 3

STATE OF NORTH CAROLINA GENERAL COURT OF JUSTICE SUPERIOR COURT DIVISION WAKE COUNTY 97-CVS-11278

KAREN BRUGGERS, D.D.S., ) ) Plaintiff, ) ) v. ) ) ) ORDER AND OPINION EASTMAN KODAK COMPANY, ) E.I. DUPONT DE NEMOURS & CO., ) BAYER CORPORATION and FUJI ) MEDICAL SYSTEMS U.S.A., INC., ) ) Defendants. )

{1} This matter is before the Court on defendant Eastman Kodak Company’s motion to dismiss for failure to state a claim pursuant to Rule 12(b) (6) of the North Carolina Rules of Civil Procedure.[fn1] For reasons set forth below, it appears to the Court that the complaint states a cause of action for which relief can be granted. In so holding, the Court determines as a matter of law that indirect purchasers have standing to sue under N.C.G.S. § 75-16. Therefore, the defendant’s motion to dismiss is DENIED.

The Blount Law Firm, P.L.L.C., by Marvin K. Blount, Jr.; Leibenberg & White, by Roberta D. Liebenberg and Robert G. Eisler; Frank & Rosen, by Alan L. Frank and David T. Shulick; Leiff, Cabraser, Heimann & Bernstein, by Joseph R. Saveri; Levin, Fishbein, Sedran & Berman, by Howard Sedran; and Hoffman & Edelson, by Marc Edelson, for Plaintiff Karen Bruggers, D.D.S.

Nigle B. Barrow, Jr.; and Pitney, Harden, Kipp & Szuch, by Clyde A. Szuch and Murray J. Laulicht, for Defendant Bayer Corporation.

Smith, Helms, Mulliss & Moore, L.L.P., by James L. Gale and Matthew W. Sawchak; and Jones, Day, Reavis & Pogue, by Thomas Demitrack and Deborah P. Herman, for Defendant FUJI Medical Systems, U.S.A., Inc.

Womble Carlyle Sandridge & Rice, by Pressly M. Millen; and Hallenbeck, Lascell, Norris & Heller, by David M. Lascell, for Defendant Eastman Kodak Company.

Parker, Poe, Adams & Bernstein L.L.P., by John F. Graybeal; and Crowell & Moring L.L.P., by George D. Ruttinger and David M. Schnorrenberg, for Defendant E.I. DuPont de Nemours & Co.

I.

{2} When ruling on a motion to dismiss under Rule 12(b)(6), the court must determine “whether, as a matter of law, the allegations of the complaint . . . are sufficient to state a claim upon which relief may be granted.” Harris v. NCNB, 85 N.C. App. 669, 670, 355 S.E.2d 838, 840 (1987). In ruling on a motion to dismiss, the court must treat the allegations in the complaint as true. See Hyde v. Abbott Laboratories, Inc., 123 N.C. App. 572, 473 S.E.2d 680, 682 (1996). The court must construe the complaint liberally and must not dismiss the complaint unless it appears to a legal certainty that plaintiff is entitled to no relief under any state of facts which could be proved in support of the claim. See id. Kodak’s motion raises the narrow, but significant, legal issue of whether indirect purchasers have standing to sue under North Carolina’s antitrust laws.

II.

{3} Plaintiff brings this class action against the manufacturers of medical x-ray film, claiming they agreed or conspired to raise and then fix prices. Although the class has not yet been certified, plaintiff’s amended complaint defines the class as “[a]ll persons and entities (excluding defendants, their co-conspirators, their parents, subsidiaries and affiliates, and all government entities) that indirectly purchased medical x-ray film within the state of North Carolina produced by any defendant or co-conspirator between 1989 and 1994.” (Amend. Compl. ¶19.) The class of indirect purchasers in this action could conceivably include dentists and other health care providers, hospitals, insurance companies, and patients. Plaintiff, a dentist, is an indirect purchaser of medical x-ray film. Plaintiff alleges that during the relevant time period, defendants were the major producers and sellers of medical x-ray film throughout the United States. Defendants sold medical x-ray film to distributors, who, in turn, sold the film to members of the proposed class.

{4} Plaintiff’s complaint sets forth claims of fraudulent concealment and restraint of trade or commerce in violation of North Carolina’s antitrust law, N.C.G.S. § 75-16. Defendant brings this motion to dismiss on the grounds that plaintiff was an indirect purchaser and therefore has no standing to bring an action against defendant for antitrust violations. Plaintiff admits she was an indirect purchaser and relies on the holding in Hyde v. Abbott Laboratories, Inc., 123 N.C. App. 572, 473 S.E.2d 680 (1996), to support her standing to sue under state antitrust laws. Eastman Kodak contends that the issue of indirect purchaser standing has not been definitively resolved by the North Carolina Supreme Court and that the state of North Carolina would not recognize indirect purchaser standing under its antitrust laws. (Def.’s Mem. Supp. Dismiss at 8-11, 18-19.) The majority of states follow the federal rule and do not permit indirect purchaser standing, either by statute or case precedent. See Stifflear v. Bristol- Myers Squibb Co., 931 P.2d 471 (Colo. Ct. App. 1996); Abbott Labs. v. Segura, 907 S.W.2d 503 (Tex. 1995); Blewett v. Abbott Labs., 938 P.2d 842 (Wash. Ct. App. 1995).

{5} The Hyde decision is the only North Carolina appellate decision dealing with indirect purchaser standing. That case was settled after the Court of Appeal’s decision and before review by the North Carolina Supreme Court. In Hyde, plaintiffs filed a class action against manufacturers of infant formula, alleging violations of North Carolina’s antitrust laws. 123 N.C. App. at 573, 473 S.E.2d at 681. The purported class consisted of ultimate consumers who purchased infant formula from parties other than the manufacturer. Id. at 574, 473 S.E.2d at 681-82. The defendants filed a motion to dismiss alleging that plaintiffs were indirect purchasers and therefore lacked standing to sue under N.C.G.S. § 75-16. Id. The Superior Court granted the motion to dismiss, and plaintiffs appealed. Id.

{6} The Court of Appeals reversed the Superior Court and found that under North Carolina’s antitrust statute, an indirect purchaser may sue a manufacturer for antitrust violations. The Court of Appeals based this finding upon a review of the plain language of N.C.G.S. § 75-16. North Carolina’s antitrust statute provides:

If any person shall be injured or the business of any person, firm or corporation shall be broken up, destroyed, or injured by reason of any act or thing done by any other person, firm or corporation in violation of the provisions of this Chapter, such person, firm or corporation so injured shall have a right of action on account of such injury done, and if damages are assessed in such case judgment shall be rendered in favor of the plaintiff and against the defendant for treble the amount fixed by the verdict.

N.C.G.S. § 75-16 (1999).

{7} The current version of N.C.G.S. § 75-16 was amended in 1969. Prior to the amendment, the first sentence of the provision began: “If the business of any person, firm, or corporation shall be broken up . . . .” 1913 N.C. Sess. L. 66, 70. The Hyde court found it significant that, in amending the statute, the legislature decided to add the phrase “if any person shall be injured” to the beginning of the provision. 123 N.C. App. at 578, 473 S.E.2d at 684.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Teague v. Bayer Ag
2007 NCBC 12 (North Carolina Business Court, 2007)
Adams v. Aventis, S.A.
2003 NCBC 7 (North Carolina Business Court, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
2000 NCBC 3, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bruggers-v-eastman-kodak-co-ncbizct-2000.